Loading clinical trials...
Loading clinical trials...
Finding New Criteria for a Revised Primary Graft Dysfunction Score in Lung Transplantation - a Pilot Study
The validity of several functional parameters, which could be included in a new PGD scoring system, will be tested in a prospective pilot study of 80 consecutive bilateral lung transplant recipients in high volume lung transplant centers. Functional parameters will be collected at different time points within the first 72hrs after lung transplantation and their accuracy in predicting clinical outcome as well as their correlation with lung water content (measured by PiCCO) will be tested. Insights will serve to generate a hypothesis (a novel PGD score), which can then be tested in future prospective trials.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Medical University of Vienna
Vienna, Austria
Toronto General Hospital
Toronto, Ontario, Canada
Start Date
November 1, 2016
Primary Completion Date
December 1, 2017
Completion Date
March 1, 2018
Last Updated
September 8, 2017
80
ESTIMATED participants
PiCCO Catheter
DEVICE
Lead Sponsor
Assoc.-Prof. Dr. Konrad Hoetzenecker, PhD
NCT05916495
NCT05950724
NCT05691205
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions